Background: Hypertensive disorders complicate 5-10% of all pregnancies and together forms the deadly triad-along with hemorrhage and heart disease that contributes greatly to maternal morbidity and mortality. Objective of this study was to determine the prevalence of hypertensive disorders of pregnancy and its maternal complications in patients attending obstetrics and gynaecology department, Government Mohan Kumaramangalam Medical College Hospital, Salem. Methods: This is a prospective study conducted from August 2018 to July 2019 in the department of obstetrics and gynaecology. Patients diagnosed with hypertensive disorders of pregnancy was evaluated and data were collected. Results: A total of 19,383 pregnant women visited obstetrics and gynaecology department over a period of one year, out of which 2028 were diagnosed with hypertensive disorders of pregnancy. Hence the prevalence of hypertensive disorders in pregnancy is 10.4%. Among 2028 hypertensive disorder cases, Gestational hypertension were 962 cases (47.4%), pre-eclampsia 661 cases (32.6%), chronic hypertension 166 cases (8.2%) and pre-eclampsia superimposed on chronic hypertension 239 cases (11.8%). The prevalence was highest among primigravida (54%) compared to multigravida (46%). Hypertensive disorders were highest among the age group of 18-22 years in our study. Most common maternal complication in our study was HELLP syndrome. Conclusions: Prevalence of hypertensive disorders was high in our study. Early detection and timely intervention decrease the maternal complications.
INTRODUCTION
Hypertensive disorders complicate 5-10% of all pregnancies and together forms the deadly triad-along with hemorrhage and heart disease that contributes greatly to maternal morbidity and mortality. 1 WHO reported 14% of maternal death attributed to hypertensive disorders of pregnancy. 2 ACOG classified hypertensive disorders of pregnancy into four groups. 3 (1) Gestational hypertension: diagnosed when systolic blood pressure > 140 mmHg or diastolic blood pressure > 90 mmHg measured on two occasions four to six hours apart after 20 weeks of pregnancy in absence of proteinuria or systemic signs and symptoms. (2) Pre-eclampsia: systolic blood pressure > 140 mmHg or diastolic blood pressure > 90 mmHg with proteinuria with or without systemic signs and symptoms/eclampsia (pre-eclampsia with convulsion). (3) Chronic hypertension: systolic blood pressure > 140 mmHg or diastolic blood pressure > 90 mmHg present pre-pregnancy or < 20 weeks of gestational age. (4) Pre-eclampsia superimposed on Chronic hypertension: increased blood pressure and new onset proteinuria or other end organ dysfunction in addition to pre-existing hypertension.
The main maternal and fetal risk associated with hypertensive disorders of pregnancy include HELLP syndrome, abruptio placenta, pulmonary edema, postpartum hemorrhage, acute renal failure, preterm delivery, fetal growth restriction, perinatal death. 4 HELLP syndrome characterised by hemolysis, elevated liver enzymes and low platelet count. HELLP syndrome is diagnosed when lactate dehydrogenase is more than 600 U/L, peripheral blood smear showing schistocytes, burr cells and helmet cells, alanine and aspartate transaminase levels are more than two times the upper limit of normal, serum bilirubin more than 1.2 mg/dl and platelet less than 100x103/microL.
METHODS
This is a prospective study conducted in the department of obstetrics and gynaecology, Government Mohan Kumaramangalam Medical College Hospital, Salem, over a period of one year from August 2018 to July 2019. All pregnant women attending outpatient department were screened for hypertensive disorders of pregnancy and evaluated. Patients subjected to detailed history taking, general examination, systemic and obstetric examination. Blood pressure was measured as per standard guidelines for all pregnant women and all necessary investigations taken to categories the patients into gestational hypertension, pre-eclampsia, chronic hypertension, preeclampsia superimposed on chronic hypertension. All patients with hypertensive disorders of pregnancy in our study were treated with anti-hypertensives. All cases of severe preeclampsia/eclampsia were treated with MgSO4 Pritchards or zuspan regimen. Fetal wellbeing and amniotic fluid volume evaluated by physical examination and sonography. Dexamethasone were given to patients less than 37 weeks of gestation for fetal lung maturity. Cases beyond 37 weeks of gestation are planned for delivery. Cases of severe preeclampsia demands termination of pregnancy. Obstetric management done following standard protocols. Maternal outcome in terms of complications like HELLP syndrome, abruptio placenta, pulmonary edema, postpartum hemorrhage and acute renal failure were noted. This is a prospective observational study confirmed by chi square test.
Inclusion criteria
• All pregnant women attending department of obstetrics and gynaecology who were diagnosed as hypertensive disorders of pregnancy were taken for this study.
Exclusion criteria
• Patients diagnosed with other causes of convulsion were excluded in this study.
RESULTS
A total of 19,383 pregnant women visited ante-natal clinic over a period of one year from August 2018 to July 2019. Out of which 2028 cases (10.4%) diagnosed with hypertensive disorders of pregnancy. Table 1 shows prevalence of hypertensive disorders in which gestational hypertension (47.4%) was most common followed by pre-eclampsia (32.6%), preeclampsia superimposed on chronic hypertension (11.8%) and chronic hypertension (8.2%). Table 2 shows age distribution of cases, in which hypertensive disorders were highest in the age group of 18-22 years of age (39.6%) followed by 30.4% of patients in the age group of 23-27 years of age, 16.5% of patients in the age group of 28-32 years of age and 13.5% of patients in the age group of more than 33 years of age. Table 3 shows gravida wise distribution, majority were seen among primigravida (54%) than multigravida (46%). Table 4 shows case distribution according to maternal complication, most common maternal complication in our study was HELLP syndrome (6.4%) followed by abruptio placenta (5%), pulmonary edema (4.2%), postpartum hemorrhage (2.9%) and acute renal failure (1%).
DISCUSSION
Hypertensive disorders of pregnancy cause most detrimental effect on both mother and fetus. This disease is one of the major public health problems responsible for increase in maternal and perinatal morbidity and mortality. Some of the risk factors for preeclampsia are primi paternity, extremes of maternal age, multifetal gestation, pregnancies through assisted reproductive technique, pre-eclampsia in previous pregnancies, renal disease, connective tissue disorders and family history of pre-eclampsia. Smoking reduces the risk of hypertension during pregnancy. 5 Primary cause behind pre-eclampsia is failure of second wave of cytotrophoblastic invasion of spiral arterioles in the muscular layer. Other causes include immunological intolerance between maternal, placental and fetal tissues, maternal maladaptation to inflammatory or cardiovascular changes of normal pregnancy and genetic influences.
In this study, overall prevalence of hypertensive disorders of pregnancy were 10.4%, gestational hypertension was diagnosed in 962 cases (47.4%), pre-eclampsia 661 cases (32.6%), chronic hypertension 166 cases (8.2%), severe pre-eclampsia superimposed on chronic hypertension 239 cases (11.8%). Incidence of pre-eclampsia in India in hospital practice varies from 5-15% and eclampsia about 1.5%. 6 Bindu K et al, reported the prevalence of PIH was 10.7% among primipara and 9.1% among multipara. 7 In the present study, the incidence was 39.6% in the age group of 18-22 years, 30.4% in the age group of 23-27 years. In Gogaram et al study highest incidence of hypertensive disorders occurred among 23-27 years of age group. 8 In our study the prevalence were highest among primigravida (54%) compared to multigravida (46%). Kolluru V et al, reported in their study that incidence of hypertensive disorders in primigavida as 48.3% and multigravida as 50.9%. 9 The present study revealed that HELLP syndrome as commonest maternal complication affecting 6.4% and abruptio placenta were next common complication affecting 4.7%. Other major complications included pulmonary edema 4.2%, post-partum hemorrhage 2.9% and acute renal failure 1%. Gandhi MR et al, reported eclampsia as a most common complication affecting 11.6% followed by HELLP syndrome 5.26%, abruptio placenta 5.26% and post-partum hemorrhage 5.26%. 10 Adu-Bonsaffoh K et al, reported that 31.7% of mothers died of hypertensive disorders of pregnancy. 11
CONCLUSION
Hypertensive disorders of pregnancy are the major health problem and it is the major cause contributing to maternal morbidity and mortality. Gestational hypertension cannot be prevented but development of pre-eclampsia and its complications can be prevented through early diagnosis and proper management, thereby reducing maternal morbidity and mortality. Though the prevalence of preeclampsia are on declining trend, it pose a major contributor of poor maternal and fetal outcome. Early detection of cases through proper antenatal checkup at all health care levels along with early initiation of antihypertensive drugs to overcome adverse maternal outcome. Proper follow up of cases helps to prevent its maternal and fetal complications.
